Optimal Anesthesia for Morbidly Obese Patients
Launched by TAIPEI MEDICAL UNIVERSITY SHUANG HO HOSPITAL · May 14, 2020
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The investigators will conduct a clinical trial using permuted block randomization and conforming to the CONSORT Statement to investigate multiple clinical outcomes in obese patients undergoing LSG at Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan. Three randomizations will be conducted, including radial artery catheterization using ultrasound guidance or blind palpitation, preoxygenation using HFNC or CPAP, and volatile anesthesia with desflurane or sevoflurane with or without M-Entropy guidance. A computer-generated list of randomizations (Research Randomizer, www....
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 20 to 65 years
- • BMI ≥ 30 kg/m2
- • Undergoing laparoscopic sleeve gastrectomy at Shuang-Ho Hospital, Taiwan
- Exclusion Criteria:
- • Severe cardiopulmonary disease
- • Psychiatric disorder
- • History of head and neck surgery or radiation therapy
- • Cervical spine injury
- • Renal insufficiency (estimated creatinine clearance \< 60 ml/min)
- • SpO2 \< 90% in room air
- • Hemodynamic instability
- • Preexisting arterial catheterization during the same visit within 7 days
- • Patient refusal
About Taipei Medical University Shuang Ho Hospital
Taipei Medical University Shuang Ho Hospital is a leading healthcare institution in Taiwan dedicated to advancing medical research and clinical care. As an integral part of Taipei Medical University, the hospital emphasizes innovation and excellence in patient treatment while fostering a collaborative environment for clinical trials. With a strong focus on multidisciplinary approaches and cutting-edge technology, the hospital aims to enhance health outcomes through rigorous research and evidence-based practices. Its commitment to high standards in clinical trial management ensures the integrity and reliability of its studies, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Taipei City, , Taiwan
Patients applied
Trial Officials
Ying-Hsuan Tai, M.D., M.Sc.
Principal Investigator
Department of Anesthesiolgy, Shuang-Ho Hospital, Taipei Medical University, Taiwan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials